Alpha-blocker therapy does not decrease the risk for prostate cancer death, but it is associated with an elevated risk for low-grade prostate cancer. Preclinical studies have suggested that ...

The original version of this Article contained errors in the legends of Figure 2 and Figure 3, which were inadvertently switched. The Legend of Figure 2 “Network plot comparing individual α-blockers ...

Old man taking a pill New study is the largest to date assessing cardiovascular risks in patients taking alpha blockers. Men who take alpha blockers (ABs) rather than 5-alpha reductase inhibitors ...

Dublin, June 25, 2019 (GLOBE NEWSWIRE) -- The "Global Benign Prostatic Hyperplasia Market: Growth, Trends, and Forecasts (2019-2024)" report has been added to ResearchAndMarkets.com's offering. Benign ...

Dear Dr. Roach: I’m a 73-year-old male in good health. I’m starting to show signs of prostate troubles. I have trouble starting to urinate, and the stream stops and starts, usually at night before bed ...

Postoperative medication use is an important yet relatively unexplored element of the benign prostatic hyperplasia patient journey. We assessed and compared the percentage of patients who required ...

OXFORD, UK / ACCESS Newswire / June 15, 2026 /Fine Treatment has highlighted increasing interest in non-invasive therapeutic ...

According to Prostate Cancer UK, prostate cancer is the most common cancer in men: 1 in 8 men will get it and if you’re over 50, or you’re Black, or you have a family history of the disease, then your ...

DEAR DR. ROACH: I am 71 and began having urinary issues due to benign prostatic hyperplasia many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn’t provide any ...

Benign prostate hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, which is generally the shape and size of a walnut. The prostate surrounds the urethra, the tube that carries ...